Ventana Biotech is trading at 0.0482 as of the 3rd of November 2025, a 10.74 percent decrease since the beginning of the trading day. The stock's open price was 0.054. Ventana Biotech has over 56 % chance of experiencing financial distress in the next 2 years of operation, but had a somewhat fair returns during the last 90 days. The performance scores are derived for the period starting the 5th of August 2025 and ending today, the 3rd of November 2025. Click here to learn more.
Ventana Biotech, Inc., a development stage biotech company, identifies, evaluates, acquires, develops, and partners commercialization of intellectual property in the area of drug candidates for personalized medicine. Ventana Biotech, Inc. was founded in 1989 and is based in Butschwil, Switzerland. The company has 55.07 M outstanding shares. More on Ventana Biotech
Ventana Biotech [VNTA] is a Pink Sheet which is traded between independent brokers as part of over-the-counter (OTC) trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 192.73 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Ventana Biotech's market, we take the total number of its shares issued and multiply it by Ventana Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Ventana Biotech conducts business under Financial Services sector and is part of Shell Companies industry. The entity has 55.07 M outstanding shares.
Ventana Biotech generates negative cash flow from operations
Check Ventana Biotech Probability Of Bankruptcy
Our tools can tell you how much better you can do entering a position in Ventana Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Balance Of Power Now
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Other Information on Investing in Ventana Pink Sheet
Ventana Biotech financial ratios help investors to determine whether Ventana Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ventana with respect to the benefits of owning Ventana Biotech security.